Does 18F-fluorodeoxyglucose PET/CT have a role in the management of pulmonary and extra pulmonary sarcoidosis?

https://doi.org/10.4081/monaldi.2008.402

Authors

  • R. Carbone Pneumology, Nuclear Medicine, Regional Hospital, Aosta, Italy.
  • A. Douroukas PET Center IRMET SpA, Turin, Italy.
  • V. Arena PET Center IRMET SpA, Turin, Italy.
  • D. Cantalupi Pneumology, Nuclear Medicine, Regional Hospital, Aosta, Italy.
  • E. Balleari DIMI, University of Genoa, Genoa, Italy.
  • R. Ghio DIMI, University of Genoa, Genoa, Italy.
  • E. Pelosi | epelosi@irmet.com PET Center IRMET SpA, Turin, Italy.

Abstract

-

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2016-01-26
Info
Issue
Section
Letters to the Editor
Statistics
  • Abstract views: 280

  • PDF: 212
How to Cite
Carbone, R., A. Douroukas, V. Arena, D. Cantalupi, E. Balleari, R. Ghio, and E. Pelosi. 2016. “Does 18F-Fluorodeoxyglucose PET/CT Have a Role in the Management of Pulmonary and Extra Pulmonary Sarcoidosis?”. Monaldi Archives for Chest Disease 69 (2). https://doi.org/10.4081/monaldi.2008.402.